Page 1381 - Veterinary Immunology, 10th Edition
P. 1381

blocking agent in a manner similar to cyclosporine (see Fig. 41.4). It
  VetBooks.ir  inhibits the production of several key cytokines, including IL-2, IL-

               3, IL-4, IL-5, IFN-γ, and TNF-α. Tacrolimus is much more potent
               than cyclosporine in inhibiting T and B cell responses. It is also

               superior to cyclosporine in preventing or reversing allograft and
               xenograft rejection in humans and can prevent graft vascular
               disease (Chapter 34). Unfortunately, it causes severe intestinal
               toxicity in dogs, resulting in ulceration, vasculitis, anorexia, and

               vomiting. Topical tacrolimus has been used successfully to treat
               atopic dermatitis, discoid lupus erythematosus, and pemphigus
               erythematosus in dogs.



               Target of Rapamycin Inhibitors


               The macrolide antibiotic rapamycin (sirolimus) and the related
               molecule everolimus specifically inhibit a multifunctional serine
               kinase known as mechanistic target of rapamycin (mTOR). mTOR

               plays a critical role in regulating T cell activation by integrating the
               signals received from specific antigen, co-stimulatory receptors, and
               cytokines, and directing the T cell differentiation into effector,
               regulatory, or memory pathways (Fig. 41.5). mTOR also acts in
               nondividing macrophages and dendritic cells by associating with

               MyD88, activating IFN regulatory factors, and inhibiting caspase-1.
               Rapamycin acts on macrophages and dendritic cells, enhancing IL-
               12 and nitric oxide production but inhibiting IL-10. This in turn

               promotes Th1- or Th17-mediated inflammation. Rapamycin inhibits
               B and T cell proliferation by blocking stimulatory signals from IL-2,
               IL-4, and IL-6. It enhances regulatory T (Treg) cell production and
               promotes tolerance. It acts synergistically with calcineurin
               inhibitors and is much superior to cyclosporine in preventing or

               reversing allograft and xenograft rejection in humans. Because it
               blocks endothelial cell and fibroblast proliferation, rapamycin can
               prevent graft vascular disease (Chapter 34), although it also inhibits

               wound healing. When given to aged mice, rapamycin significantly
               increases their life span. It is believed to act as a dietary restriction
               mimetic. Unfortunately, it also induces severe intestinal toxicity in
               dogs, causing ulceration, vasculitis, anorexia, and vomiting.








                                                        1381
   1376   1377   1378   1379   1380   1381   1382   1383   1384   1385   1386